Infliximab

Renflexis

100 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 22 Mar 2018

In other countries

The same active substances on other registers, the same brand first.

renflexisBrazil · Samsung Bioepis br Pharmaceutical ltda.Same brand
RenflexisUnited States · 100MG · injectable · Samsung Bioepis Co LTDSame brand
Remicade®Serbia · 100mg · prašak za koncentrat za rastvor za infuziju · PredstavniŠTvo Janssen-Cilag KFT BeogradSame form
RemsimaSerbia · 100mg · prašak za koncentrat za rastvor za infuziju · Oktal Pharma DOO BeogradSame form
RemsimaSerbia · 100mg · prašak za koncentrat za rastvor za infuziju · Oktal Pharma DOO BeogradSame form
AvsolaBrazil · Amgen Biotecnologia do Brasil Ltda.Same substance
Bio Manguinhos InfliximabeBrazil · Fundação Oswaldo CruzSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Infliximab

Renflexis

100 MG / VIAL Powder For SolutionCanadaMarketedAuthorised 22 Mar 2018

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Flixabi 100MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 100.00 mg · polvo para concentrado para solución para perfusión · Samsung Bioepis Nl B.V.

Remicade 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 100 mg · polvo para concentrado para solución para perfusión · Janssen-Cilag International N.V

Remsima 100 MG Polvo Para Concentrado Para Solucion Para PerfusionSpain · 100 mg · polvo para concentrado para solución para perfusión · Celltrion Healthcare Hungary Kft.

FlixabiEuropean Union · Samsung Bioepis NL B.V.

InflectraEuropean Union · Pfizer Europe MA EEIG

RemicadeEuropean Union · Janssen Cilag International NV

FlixabiCroatia

RemicadeCroatia

RemsimaCroatia

FlixabiItaly · Polvere per concentrato per soluzione per infusione · Samsung Bioepis NL B.V.

RemicadeItaly · Polvere per concentrato per soluzione per infusione · Janssen-Cilag International N.V.

RemsimaItaly · Concentrato per soluzione per infusione · Celltrion Healthcare Hungary KFT

Flixabi 100 mg, poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Samsung Bioepis NL B.V.

Remicade 100 mg, poeder voor oplossing voor infusieNetherlands · Poeder voor oplossing voor infusie · Janssen-Cilag International NV

Remsima 100 mg, poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Celltrion Healthcare Hungary Kft.

RemicadeNew Zealand · Inj 100 mg

INFLECTRA 100 mgRomania · 100mg · pulb. pt. conc. pt. sol. perf. · Pfizer Europe Ma Eeig

INFLECTRA 100mgRomania · 100mg · pulb. pt. conc. pt. sol. perf. · Hospira UK Limited

REMICADE 100 mgRomania · 100mg · pulb. pt. conc. pt. sol. perf. · Janssen Biologics B.V.

IxifiSaudi Arabia · Pfizer

IxifiSaudi Arabia · Pfizer Manufacturing Belgium N.V.

Remicade 100MG Vial for InjSaudi Arabia · Janssen-Cilag

Ixifi Powder for Concentrate for Solution for Infusion 100 MG/ VialSingapore · 100mg / vial · injection, powder, lyophilized, for solution · Pfizer Private Limited

REMICADE POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100 mg/vialSingapore · 100 mg/vial · injection, powder, for solution · Johnson & Johnson International (Singapore) Pte LTD

Remsima® Powder for Concentrate for Solution for Infusion 100 MG/VialSingapore · 100mg/vial · injection, powder, lyophilized, for suspension · Celltrion Healthcare Singapore Private Limited

Ixifi powder for concentrate for solution for infusionTaiwan · 凍晶注射劑 · 美商惠氏藥廠（亞洲）股份有限公司台灣分公司

AvsolaUnited States · 100MG/VIAL · injectable · Amgen INC

IxifiUnited States · 100MG/VIAL · injectable · Pfizer INC

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Infliximab
Strength: 100 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 22 Mar 2018
Registration: DIN 02470373
Marketing authorisation holder: Samsung Bioepis Co., LTD
ATC code: L04AB02
Group: Antineoplastic and immunomodulating agents
Supply: PRESCRIPTION, SCHEDULE D

Health Canada

RemdantryInfliximab · 100 MG / VIAL · Powder For SolutionCanada

RemicadeInfliximab · 100 MG / VIAL · Powder For SolutionCanada

Remsima SCInfliximab · 120 MG / ML · Kit, SolutionCanada

OmvyenceInfliximab · 100 MG / VIAL · Powder For SolutionCanada

Remsima SCInfliximab · 120 MG / ML · Kit, SolutionCanada

RemsimaInfliximab · 100 MG / VIAL · Powder For SolutionCanadaCancelled